A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system
Geoffrey J. Gorse, Stephen Grimes, Helen Buck, Hussain Mulla, Peter White, Heather Hill, Jeanine May, Sharon E. Frey, Peter Blackburn
Topics & Concepts
ReactogenicityMedicineAdjuvantImmunogenicityInfluenza vaccineVaccinationAdverse effectSeroconversionmyalgiaAntibody titerTiterInternal medicineGastroenterologyAntibodyImmunologyInfluenza Virus Research StudiesIntramuscular injections and effectsInfection Control and Ventilation